Clinical Trial Update: JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for JZP898 as monotherapy and in combination with pembrolizumab in adults with advanced or metastatic solid tumors; recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• JZP898
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | Status: RECRUITING